Determination of the Anti-Escherichial Activity of the Pyrimidine Derivative 3-[2-[(4,6-dimethylpyrimidin-2- yl)amino]-2-oxoethyl]quinazolin-4(3H)-one

The aim of this study was to investigate the antimicrobial activity of the pyrimidine derivative 3-[2-[(4,6-dimethylpyrimidin-2-yl)amino]-2-oxoethyl]quinazolin-4(3H)-one against Escherichia coli. The study of antimicrobial activity was carried out in vitro by serial dilutions of the pyrimidine compo...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Tsibizova, A. L. Yasenyavskaya, I. N. Tyurenkov, А. А. Ozerov, M. А. Samotrueva
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2023-12-01
Series:Антибиотики и Химиотерапия
Subjects:
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/1057
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849693080338300928
author A. A. Tsibizova
A. L. Yasenyavskaya
I. N. Tyurenkov
А. А. Ozerov
M. А. Samotrueva
author_facet A. A. Tsibizova
A. L. Yasenyavskaya
I. N. Tyurenkov
А. А. Ozerov
M. А. Samotrueva
author_sort A. A. Tsibizova
collection DOAJ
description The aim of this study was to investigate the antimicrobial activity of the pyrimidine derivative 3-[2-[(4,6-dimethylpyrimidin-2-yl)amino]-2-oxoethyl]quinazolin-4(3H)-one against Escherichia coli. The study of antimicrobial activity was carried out in vitro by serial dilutions of the pyrimidine compound, followed by determination of the minimum inhibitory concentration of 3-[2-[(4,6-dimethylpyrimidin-2-yl)amino]-2-oxoethyl]quinazolin-4(3n)-one (VMA-13-14) and in vivo on the model of generalized E.coli infection. The study of antimicrobial activity in vivo was carried out on 40 CBA mice weighing 19–20 g. All manipulations with animals were performed in accordance with the requirements of the regulatory documentation governing the maintenance of laboratory animals and work involving them. The antimicrobial activity of the pyrimidine compound 3-[2-[(4,6-dimethylpyrimidin-2-yl)amino]-2-oxoethyl]quinazolin-4(3H)-one against E.coli in vitro was evaluated in terms of mouse survival, contamination of blood and internal organs (liver, spleen, lungs, brain), as well as the total number of leukocytes and leukograms. The experiment determined that the pyrimidine compound 3-[2-[(4,6-di- methylpyrimidin-2-yl)amino]-2-oxoethyl]quinazolin-4(3n)-one demonstrates antimicrobial activity against E.coli: in vitro, it has a bactericidal effect at a concentration of 128 µg/ml; in vivo, it has an antimicrobial effect in conditions of generalized infection with the introduction of 50 mg/kg/day for 10 days. The antimicrobial effect of 3-[2-[(4,6-dimethylpyrimidin-2- yl)amino]-2-oxoethyl]quinazolin-4(3n)-one is comparable to ceftazidime, which is the drug of choice in the treatment of E.coli infection.
format Article
id doaj-art-da85b15eec3e49e0838ba3f00afb1b10
institution DOAJ
issn 0235-2990
language Russian
publishDate 2023-12-01
publisher LLC "Publishing House OKI"
record_format Article
series Антибиотики и Химиотерапия
spelling doaj-art-da85b15eec3e49e0838ba3f00afb1b102025-08-20T03:20:32ZrusLLC "Publishing House OKI"Антибиотики и Химиотерапия0235-29902023-12-01687-841010.37489/0235-2990-2023-68-7-8-4-10973Determination of the Anti-Escherichial Activity of the Pyrimidine Derivative 3-[2-[(4,6-dimethylpyrimidin-2- yl)amino]-2-oxoethyl]quinazolin-4(3H)-oneA. A. Tsibizova0A. L. Yasenyavskaya1I. N. Tyurenkov2А. А. Ozerov3M. А. Samotrueva4Astrakhan State Medical UniversityAstrakhan State Medical UniversityVolgograd State Medical UniversityVolgograd State Medical UniversityAstrakhan State Medical UniversityThe aim of this study was to investigate the antimicrobial activity of the pyrimidine derivative 3-[2-[(4,6-dimethylpyrimidin-2-yl)amino]-2-oxoethyl]quinazolin-4(3H)-one against Escherichia coli. The study of antimicrobial activity was carried out in vitro by serial dilutions of the pyrimidine compound, followed by determination of the minimum inhibitory concentration of 3-[2-[(4,6-dimethylpyrimidin-2-yl)amino]-2-oxoethyl]quinazolin-4(3n)-one (VMA-13-14) and in vivo on the model of generalized E.coli infection. The study of antimicrobial activity in vivo was carried out on 40 CBA mice weighing 19–20 g. All manipulations with animals were performed in accordance with the requirements of the regulatory documentation governing the maintenance of laboratory animals and work involving them. The antimicrobial activity of the pyrimidine compound 3-[2-[(4,6-dimethylpyrimidin-2-yl)amino]-2-oxoethyl]quinazolin-4(3H)-one against E.coli in vitro was evaluated in terms of mouse survival, contamination of blood and internal organs (liver, spleen, lungs, brain), as well as the total number of leukocytes and leukograms. The experiment determined that the pyrimidine compound 3-[2-[(4,6-di- methylpyrimidin-2-yl)amino]-2-oxoethyl]quinazolin-4(3n)-one demonstrates antimicrobial activity against E.coli: in vitro, it has a bactericidal effect at a concentration of 128 µg/ml; in vivo, it has an antimicrobial effect in conditions of generalized infection with the introduction of 50 mg/kg/day for 10 days. The antimicrobial effect of 3-[2-[(4,6-dimethylpyrimidin-2- yl)amino]-2-oxoethyl]quinazolin-4(3n)-one is comparable to ceftazidime, which is the drug of choice in the treatment of E.coli infection.https://www.antibiotics-chemotherapy.ru/jour/article/view/1057escherichia coligeneralized escherichial infectionbactericidal activityantimicrobial activity
spellingShingle A. A. Tsibizova
A. L. Yasenyavskaya
I. N. Tyurenkov
А. А. Ozerov
M. А. Samotrueva
Determination of the Anti-Escherichial Activity of the Pyrimidine Derivative 3-[2-[(4,6-dimethylpyrimidin-2- yl)amino]-2-oxoethyl]quinazolin-4(3H)-one
Антибиотики и Химиотерапия
escherichia coli
generalized escherichial infection
bactericidal activity
antimicrobial activity
title Determination of the Anti-Escherichial Activity of the Pyrimidine Derivative 3-[2-[(4,6-dimethylpyrimidin-2- yl)amino]-2-oxoethyl]quinazolin-4(3H)-one
title_full Determination of the Anti-Escherichial Activity of the Pyrimidine Derivative 3-[2-[(4,6-dimethylpyrimidin-2- yl)amino]-2-oxoethyl]quinazolin-4(3H)-one
title_fullStr Determination of the Anti-Escherichial Activity of the Pyrimidine Derivative 3-[2-[(4,6-dimethylpyrimidin-2- yl)amino]-2-oxoethyl]quinazolin-4(3H)-one
title_full_unstemmed Determination of the Anti-Escherichial Activity of the Pyrimidine Derivative 3-[2-[(4,6-dimethylpyrimidin-2- yl)amino]-2-oxoethyl]quinazolin-4(3H)-one
title_short Determination of the Anti-Escherichial Activity of the Pyrimidine Derivative 3-[2-[(4,6-dimethylpyrimidin-2- yl)amino]-2-oxoethyl]quinazolin-4(3H)-one
title_sort determination of the anti escherichial activity of the pyrimidine derivative 3 2 4 6 dimethylpyrimidin 2 yl amino 2 oxoethyl quinazolin 4 3h one
topic escherichia coli
generalized escherichial infection
bactericidal activity
antimicrobial activity
url https://www.antibiotics-chemotherapy.ru/jour/article/view/1057
work_keys_str_mv AT aatsibizova determinationoftheantiescherichialactivityofthepyrimidinederivative3246dimethylpyrimidin2ylamino2oxoethylquinazolin43hone
AT alyasenyavskaya determinationoftheantiescherichialactivityofthepyrimidinederivative3246dimethylpyrimidin2ylamino2oxoethylquinazolin43hone
AT intyurenkov determinationoftheantiescherichialactivityofthepyrimidinederivative3246dimethylpyrimidin2ylamino2oxoethylquinazolin43hone
AT aaozerov determinationoftheantiescherichialactivityofthepyrimidinederivative3246dimethylpyrimidin2ylamino2oxoethylquinazolin43hone
AT masamotrueva determinationoftheantiescherichialactivityofthepyrimidinederivative3246dimethylpyrimidin2ylamino2oxoethylquinazolin43hone